ARK Investment Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $105K | Buy |
4,321
+429
| +11% | +$10.4K | ﹤0.01% | 179 |
|
|
2025
Q1 | $80.8K | Sell |
3,892
-2,097
| -35% | -$43.5K | ﹤0.01% | 177 |
|
|
2024
Q4 | $141K | Buy |
5,989
+2,521
| +73% | +$59.4K | ﹤0.01% | 166 |
|
|
2024
Q3 | $88.8K | Sell |
3,468
-3,872
| -53% | -$99.1K | ﹤0.01% | 178 |
|
|
2024
Q2 | $172K | Sell |
7,340
-777
| -10% | -$18.2K | ﹤0.01% | 172 |
|
|
2024
Q1 | $233K | Sell |
8,117
-1,062
| -12% | -$30.5K | ﹤0.01% | 202 |
|
|
2023
Q4 | $301K | Buy |
9,179
+5,155
| +128% | +$169K | ﹤0.01% | 198 |
|
|
2023
Q3 | $112K | Buy |
4,024
+829
| +26% | +$23.1K | ﹤0.01% | 219 |
|
|
2023
Q2 | $109K | Sell |
3,195
-2,837
| -47% | -$96.7K | ﹤0.01% | 217 |
|
|
2023
Q1 | $181K | Sell |
6,032
-10,102
| -63% | -$304K | ﹤0.01% | 210 |
|
|
2022
Q4 | $455K | Buy |
16,134
+14,553
| +920% | +$411K | ﹤0.01% | 207 |
|
|
2022
Q3 | $52K | Sell |
1,581
-9,126
| -85% | -$300K | ﹤0.01% | 230 |
|
|
2022
Q2 | $345K | Buy |
10,707
+3,858
| +56% | +$124K | ﹤0.01% | 233 |
|
|
2022
Q1 | $315K | Sell |
6,849
-46,541
| -87% | -$2.14M | ﹤0.01% | 246 |
|
|
2021
Q4 | $3.27M | Buy |
53,390
+37,478
| +236% | +$2.3M | 0.01% | 203 |
|
|
2021
Q3 | $1.19M | Buy |
15,912
+7,521
| +90% | +$562K | ﹤0.01% | 254 |
|
|
2021
Q2 | $776K | Sell |
8,391
-2,344
| -22% | -$217K | ﹤0.01% | 256 |
|
|
2021
Q1 | $953K | Buy |
10,735
+9,065
| +543% | +$805K | ﹤0.01% | 257 |
|
|
2020
Q4 | $156K | Buy |
+1,670
| New | +$156K | ﹤0.01% | 234 |
|